PHARMACODYNAMIC EFFECTS OF ADJUNCTIVE CLOPIDOGREL THERAPY IN PATIENTS WITH ATHEROSCLEROTIC DISEASE ON DUAL PATHWAY INHIBITION WITH ASPIRIN AND LOW-DOSE RIVAROXABAN

被引：0
|
作者：
Franchi, Francesco
Rollini, Fabiana
Been, Latonya
Abou Jaoude, Patrick
Rivas, Andrea
Zhou, Xuan
Jia, Sida
Maaliki, Naji
Lee, Chang Hoon
Maldonado, Andres Pineda
Suryadevara, Siva
Soffer, Daniel
Zenni, Martin
Jennings, Lisa
Bass, Theodore
Angiolillo, Dominick
机构：
[1] Univ Florida, Coll Med, Jacksonville, FL USA
[2] CirQuest Labs, Memphis, TN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1187 / 1187
页数：1
相关论文
共 50 条
  • [41] Benefit of low-dose aspirin in critically ill patients: interaction with clopidogrel, NSAIDs and statins
    Winning, J.
    Boettel, J.
    Sossdorf, M.
    Otto, G. P.
    Loesche, W.
    INFECTION, 2013, 41 : S50 - S50
  • [42] Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
    Lee, PY
    Chen, WH
    Ng, W
    Cheng, X
    Kwok, JYY
    Tse, HF
    Lau, CP
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (07): : 723 - 727
  • [43] The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial
    Vardi, M.
    Cryer, B. L.
    Cohen, M.
    Lanas, A.
    Schnitzer, T. J.
    Lapuerta, P.
    Goldsmith, M. A.
    Laine, L.
    Doros, G.
    Liu, Y.
    McIntosh, A. I.
    Cannon, C. P.
    Bhatt, D. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (03) : 365 - 374
  • [44] Debate on "dual pathway inhibition": Antiplatelet therapy in patients with peripheral atherosclerotic disease: old but gold?
    Spaccarotella, Carmen
    Simonetti, Fiorenzo
    Piccolo, Raffaele
    Esposito, Giovanni
    GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (04) : 24S - 27S
  • [45] Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials
    Anand, Sonia S.
    Hiatt, Will
    Dyal, Leanne
    Bauersachs, Rupert
    Berkowitz, Scott D.
    Branch, Kelley R. H.
    Debus, Sebastian
    Fox, Keith A. A.
    Liang, Yan
    Muehlhofer, Eva
    Nehler, Mark
    Haskell, Lloyd P.
    Patel, Manesh
    Szarek, Michael
    Yusuf, Salim
    Eikelboom, John
    Bonaca, Marc P.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : E181 - E189
  • [46] COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE RIVAROXABAN PLUS ASPIRIN FOR THE PATIENTS WITH STABLE CARDIOVASCULAR DISEASE IN TAIWAN SETTING
    Lee, M. C.
    Liao, C. T.
    Toh, H. S.
    Sun, L.
    Chang, W. T.
    Su, H. C.
    VALUE IN HEALTH, 2019, 22 : S168 - S168
  • [47] Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease
    Weiss, Luisa
    O'Doherty, Aideen
    Uhrig, Wido
    Szklanna, Paulina B.
    Hong-Minh, Molly
    Wynne, Kieran
    Blanco, Alfonso
    Zivny, Jan
    Passos, Valeria Lima
    Kevane, Barry
    Murphy, Sean
    Ainle, Fionnuala Ni
    O'Donnell, Martin
    Maguire, Patricia B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2025, 23 (02) : 531 - 545
  • [48] EFFECTS OF LOW-DOSE ASPIRIN ON PLATELETS IN PATIENTS WITH CORONARY HEART-DISEASE (CHD)
    TERRES, W
    SCHUSTER, O
    ARTERIOSCLEROSIS, 1988, 8 (05): : A677 - A677
  • [49] Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
    Vanassche, Thomas
    Verhamme, Peter
    Anand, Sonia S.
    Shestakovska, Olga
    Leong, Darryl P.
    Fox, Keith A. A.
    Bhatt, Deepak L.
    Avezum, Alvaro
    Alings, Marco
    Aboyans, Victor
    Maggioni, Aldo P.
    Widimsky, Petr
    Muehlhofer, Eva
    Berkowitz, Scott D.
    Yusuf, Salim
    Connolly, Stuart J.
    Eikelboom, John W.
    Bosch, Jackie
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (05) : 462 - 473
  • [50] Comparison of efficacy and safety profiles of rivaroxaban and aspirin versus clopidogrel and aspirin in the prevention of atherosclerotic events in Chinese dyslipidemic patients with coronary artery disease
    Tu, Rongzu
    Lu, Zhaie
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (10) : 2247 - 2251
12345